ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

8.83 (USD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -34.566-31.963-25.011-28.33-25.478-22.944-23.945-20.847-24.829-20.287-23.159-22.771-18.426-21.009-16.509-28.259-25.548-11.024-8.872-8.354-6.549-5.965-6.015
Depreciation & Amortization 0.270.2720.2610.2630.2570.2590.2530.2470.2210.2470.2510.2290.2170.2220.2290.2340.240.2460.250.270.270.2460.242
Deferred Income Tax 000-3.4700000001.3650000.2660000000
Stock Based Compensation 5.0564.9964.9583.9233.8643.8253.6143.133.2934.0923.9453.4993.3973.2132.7441.6891.6811.3810.5270.4420.2710.190.191
Change In Working Capital 4.8013.366-8.1671.9843.634-1.0310.3112.7212.365-1.734-3.7972.6112.340.928-1.8061.3731.043-0.187-0.1840.4930.6440.0320.051
Accounts Receivables 0000000000000000.1930000000
Change In Inventory 0000000000000002.2710000000
Change In Accounts Payables 0.7570-5.7580.9793.911-0.82-0.7921.9440.5-0.158-3.2612.4791.6372.053-3.2382.0320.8961.612-0.2370.4820.292-0.1280.34
Other Working Capital 4.0443.366-2.4091.005-0.277-0.2111.1030.7771.865-1.576-0.5360.1320.703-1.1251.432-3.1230.147-1.7990.0530.0110.3520.16-0.289
Other Non Cash Items -4.19-2.2968.8431.133-1.922-1.254-0.861-0.58-0.37-0.2520.042-1.2170.330.4320.4416.87213.0041.612-0.2370.0010.0040.0030.34
Operating Cash Flow -28.629-25.625-30.354-24.497-19.645-21.145-20.628-15.329-19.32-17.776-22.718-16.284-12.142-16.214-14.901-17.825-9.58-9.584-8.279-7.148-5.36-5.494-5.531
Investing Activities:
Investments In Property Plant And Equipment 0.551-0.333-0.218-0.057-0.077-0.405-0.31-0.287-0.401-0.667-0.723-0.389-0.233-0.135-0.182-0.411-0.05-0.202-0.004-0.056-0.219-0.393-0.1
Acquisitions Net 000-0.0210.0580.0190.312.078000.7231.375000.26-124.8330000000
Purchases Of Investments -54.012-48.887-114.395-28.97-110.989-55.898-43.387-31.632-61.019-45.536-99.937-36.76-7.6950-25.171-100.845-124.64000000
Sales Maturities Of Investments 77.567.552.74549.9953.23536.9956.47560.21960.73501037.54382.566100000000
Other Investing Activites -0.9690-0.2180.021-0.058-0.019-0.31-2.078-0-45.536-0.723-1.37535.30582.5-0.26124.833-124.6400.1930000
Investing Cash Flow 23.0718.28-61.86820.963-57.831-19.31312.77828.3-0.685-46.203-90.660.35135.07282.36540.647-91.256-124.69-0.2020.189-0.056-0.219-0.393-0.1
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued -1.0140.8161250.226-0.226850250.0010.4150.0160.813500.0580.016133.3080000000
Common Stock Repurchased -10,951.21610,951.216000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities -0.0420.8160.1980.2270.0310.1740-0.2070.0010.4150.0160.813-1.414-0.2810.016-7.812-0.341126.986-1.627-0.1965.69849.92315.264
Financing Cash Flow -0.0420.816125.1980.680.03185.174025.1920.0010.4150.0160.81348.586-0.2810.016125.496-0.341126.986-1.627-0.0615.69849.92315.264
Other Information:
Effect Of Forex Changes On Cash 000-17,253.1388,696.9978,556.14100000-25.76200000000000
Net Change In Cash -5.11-6.52932.976-2.854-77.44544.716-7.8537.764-20.004-63.564-113.362-15.1271.51665.8725.76216.415-134.611117.2-9.717-7.2650.11944.0369.633
Cash At End Of Period 44.72149.83156.3623.38426.729104.17459.45867.30829.54449.548113.112226.474241.594170.078104.20878.44662.031196.64279.44289.15996.42496.30552.269